← Browse by Condition
Medical Condition

mycobacterium avium complex pulmonary disease

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for mycobacterium avium complex pulmonary disease sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 4
3
Top Sponsors
Bin Cao 3 trials
Radboud University Medical Center 1 trial
NCT05906316
Recruiting

A Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative Study

Enrollment
100 pts
Location
United States, Belgi...
Sponsor
Radboud University Medical Cen...
View Trial →
NCT07174076 Phase 4
Recruiting

Prevention of Recurrence With Cordyceps Sinensis in Mycobacterium Avium Complex Pulmonary Disease

Enrollment
300 pts
Location
China
Sponsor
Bin Cao
View Trial →
NCT07084402 Phase 4
Recruiting

Short-term Bactericidal Effect of Contezolid in MAC-PD

Enrollment
188 pts
Location
China
Sponsor
Bin Cao
View Trial →
NCT07213765 Phase 4
Recruiting

Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease

Enrollment
188 pts
Location
China
Sponsor
Bin Cao
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology